13F-HR filed by Vitruvian Partners LLP
Vitruvian Partners LLP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-06, with 7 holding rows worth $139,152,811.
- Accession
- 0001420506-26-000200
- Filer
- CIK 1692590
- Filed
- 2026-02-06
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 7 entries on the cover page, a total value of $139,152,811 stated on the cover page (in dollars after the unit check, H1), rows summing to $139,152,811 with VALUE read as dollars as filed, 13F file number 028-19384. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HINGE HEALTH INC A | 433313103 | COMMON STOCK | 1,250,000 | $58,062,500 | dollars as filed | |
| MARQETA INC | 57142B104 | CLASS A COM | 6,853,183 | $32,552,619 | dollars as filed | |
| CARGURUS INC COM CL A | 141788109 | Stock | 472,959 | $18,137,978 | dollars as filed | |
| XOMETRY INC | 98423F109 | CLASS A COM | 191,919 | $11,413,423 | dollars as filed | |
| GLOBAL-E ONLINE LTD NPV | M5216V106 | SHS | 210,209 | $8,263,316 | dollars as filed | |
| MAXCYTE INC | 57777K106 | COM | 5,043,356 | $7,817,202 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 278,865 | $2,905,773 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-000200 | this filing | 2026-02-06 | acceptance time not in the bulk data set |